0000882095 2026-05-07 2026-05-07 0000882095 1 2026-05-07 2026-05-07 shares iso4217:USD pure 0000882095 EX-FILING FEES N/A S-8 S-8 GILEAD SCIENCES, INC. Equity false Common stock, par value $0.001 per share true 47750000 130.09 6211797500 0.00013810 857849.23 6211797500 857849.23 0 857849.23 (1)    Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall also cover such indeterminate number of additional shares of common stock, par value $0.001 per share, of the Registrant (the “Common Stock”) as may become issuable to prevent dilution in the event of stock splits, stock dividends or similar transactions pursuant to the terms of the Gilead Sciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the “Plan”). The “Proposed Maximum Offering Price Per Unit” and the “Maximum Aggregate Offering Price” are estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on The Nasdaq Global Select Market, on April 30, 2026. The “Amount Registered” represents an additional 47,750,000 shares of Common Stock reserved for issuance under the Plan.